<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>E. Tsolaki | Prof. Nikolaos Korfiatis</title><link>https://nkorf.github.io/authors/e.-tsolaki/</link><atom:link href="https://nkorf.github.io/authors/e.-tsolaki/index.xml" rel="self" type="application/rss+xml"/><description>E. Tsolaki</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><item><title>Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)</title><link>https://nkorf.github.io/publications/lakis2026ccr/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/lakis2026ccr/</guid><description/></item><item><title>Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping</title><link>https://nkorf.github.io/publications/sgouros2025esmogi/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/sgouros2025esmogi/</guid><description/></item><item><title>Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)</title><link>https://nkorf.github.io/publications/lakis2025sabcs/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/lakis2025sabcs/</guid><description/></item></channel></rss>